menu search

Gilead sciences: underlying growth obscured by veklury swings

Gilead Sciences got very lucky with its Veklury anti-viral, as it proved very valuable in combating Covid-19. Meanwhile, Gilead management has been wo...

March 9, 2023, 2:00 pm

Is fulgent genetics (flgt) outperforming other medical stocks this year?

Here is how Fulgent Genetics, Inc. (FLGT) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year....

March 9, 2023, 11:25 am

Betterlife pharma's reports positive study findings for lead candidate betr-001

BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) revealed promising findings from a study on its lead candidate BETR-001 (2-bromo-LSD), a non-hallucinoge...

March 9, 2023, 9:27 am

5 large drug stocks to watch as sector picks up in 2023

Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap P...

March 9, 2023, 9:11 am

Missed out on vertex? my best gene-editing stock to buy and hold

CRISPR Therapeutics is a clinical-stage biotech company. The company's pipeline includes two promising ...

March 9, 2023, 8:50 am

Biophytis to present positive results of phase 2-3 cova study at ers 2023 21st lung science conference

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / March 9, 2023 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"),...

March 9, 2023, 2:20 am

Curis reschedules fourth quarter 2022 business update and conference call

LEXINGTON, Mass. , March 8, 2023 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeu...

March 8, 2023, 7:09 pm

Nkgen biotech announces formation of scientific advisory board to drive its pipeline strategy for natural killer cell therapies targeting neurodegenerative diseases

SANTA ANA, Calif., March 08, 2023 (GLOBE NEWSWIRE) — NKGen Biotech, a biotechnology company harnessing the power of the body’s immune system throu...

March 8, 2023, 6:27 pm

Vir biotechnology to participate in the barclays global healthcare conference

SAN FRANCISCO, March 08, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D., Executive Vice Pr...

March 8, 2023, 4:05 pm

Neurocrine biosciences to participate at investor conferences in march

Barclays Global Healthcare Conference on March 15 in Miami Jefferies biotech on the Bay Summit on March...

March 8, 2023, 4:01 pm

4 top penny stocks to watch with big biotech news this quarter

4 biotech penny stocks to watch right now. The post 4 Top Penny Stocks To Watch With Big ...

March 8, 2023, 10:44 am

Hql: boom-bust returns may not be suitable for high distribution yield

HQL focuses on the life sciences industry with a 74% allocation to biotechnology stocks. It pays a 2% quarterly managed distribution....

March 8, 2023, 3:27 am

Alexandria real estate: a blue chip reit with solid upside

Alexandria is not your typical office REIT as its unique focus on life sciences and biotech makes it re...

March 8, 2023, 12:44 am

Vertex pharmaceuticals incorporated (vrtx) 43rd annual cowen healthcare conference transcript

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) 43rd Annual Cowen Healthcare Conference March 7, 2023 2:50 PM ET Company Participants Reshma Kewalr...

March 7, 2023, 7:51 pm

Why allakos stock was heating up today

Allakos is barreling toward two mid-stage data readouts that could alter its long-term outlook. An analyst thinks these twin catalysts could cause the...

March 7, 2023, 4:05 pm

Why shares of ambrx biopharma fell tuesday

Ambrx is a clinical-stage biotech and is not profitable. The company's lead therapy is ARX788, which is...

March 7, 2023, 3:32 pm

Givaudan: growth is not without its downsides

Givaudan has been expanding through a combination of organic growth, M&A and partnerships, with a recent focus on gaining exposure to products produce...

March 7, 2023, 1:40 pm

Virios therapeutics to report fourth quarter and full year 2022 financial results on tuesday, march 14, 2023

ATLANTA, March 07, 2023 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI), a development-stage biotechnology company focused on advancing ...

March 7, 2023, 12:05 pm

Virios therapeutics to report fourth quarter and full year 2022 financial results on tuesday, march 14, 2023

ATLANTA, March 07, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI), a development-stage biotechnology company focused on advancing n...

March 7, 2023, 7:05 am

Enanta pharmaceuticals to present at the oppenheimer 33rd annual healthcare conference

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small mole...

March 7, 2023, 7:00 am


Search within

Pages Search Results: